| Identification | |
| Name: | 2DEOXYCOFORMYCIN |
| Synonyms: | pentostatin;Covidarabine;Deoxycoformycin;Vidarbine;CO-Vidarabine;2'-Deoxycoformycin;NSC218321;Co-V;PD-ADI;Vira A deaminase inhibitor;Coforin;Oncopent;Nipent;2'-DCF;2'-Dexoycoformycin;Nipent (TN);CI-825;AC1L97UQ;CHEMBL1580;53910-25-1;BIDD:GT0136;Pentostatin (JAN/USAN/INN);CHEBI:41829;CHEBI:416571;Niapent;DB00552;NSC-218321;Deaminase inhibitor;dCF;CL-67310465;C02267;D00155;AC1L24QP;CHEMBL360191;(8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol;(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol;(R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol;59979-24-7;Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-;CID439693;DAP000566;NSC247520;NSC-247520;NCI60_001818;(8R)-3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol;(R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol;Imidazo[4,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-;Imidazo[4,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8- tetrahydro-, (R)-;Imidazo[4,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)- |
| CAS: | 63677-95-2 |
| Molecular Formula: | C11H16N4O4 |
| Molecular Weight: | 0 |
| InChI: | InChI=1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6?,7-,8?,9?/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Melting Point: | 220-225 deg C |
| Solubility: | Freely soluble in water, aqueous solubility > 100 mg/ml |
| Color: | White crystals from methanol/water White to off-white solid |
| Safety Data | |
 |
|
